Affiliation:
1. Department of Internal Medicine, Army Hospital (R&R), New Delhi
Abstract
Systemic lupus erythematosus (SLE) is an inammatory systemic disease that damages organs by depositing
autoantibodies and complement-activating immune complexes or by vascular occlusion resulting from procoagulant
states linked with antiphospholipid antibodies(APLA). SLE is a chronic autoimmune disorder that affects women of childbearing age in the vast
majority of cases [5]. SLE is diagnosed by the presence of clinical manifestations (clinical domains) and auto-antibodies (Immunological
domains). SLE is becoming more prevalent. Here, we report a rare case of a young male with SLE who presented with add-on features of
inammatory myositis
Subject
History,Sociology and Political Science,Ophthalmology,General Medicine,Ophthalmology,General Medicine,Ophthalmology,Orthopedics and Sports Medicine,Physical Therapy, Sports Therapy and Rehabilitation,Education,Organizational Behavior and Human Resource Management,Sociology and Political Science,Industrial relations,Infectious Diseases,Virology,Rheumatology,Rheumatology
Reference10 articles.
1. Sreejith V Ravi, CJ Selvakumar, Inflammatory Myositis-Secondary to SLE, Journal of the association of physicians of India; vol 77,2019
2. Gary S. Firestein, Ralph C. Budd, Sherine E. Gabriel, Iain B. McInnes, James R. O'Dell, Kelley's Textbook of Rheumatology,2013,
3. Hilton-Jones D, Squier MV. Risk of cancer in dermatomyositis or polymyositis (letter). N Engl J Med 1992; 327:207-8.
4. Harvey AM, Shulman LE, Tumulty PA, et al. Systemic lupus erythematosus: a review of the literature and clinical analysis of 138 cases. Medicine 1954; 33:291-437.
5. Schroeder JO, Euler HH. Recognition and management of systemic lupus erythematosus. Drugs 1997; 54:422-34.